Clinical Trial Update: Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid

View source ↗

Summary

A clinical trial evaluating cerebral infarction and white matter changes in cerebral amyloid angiopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Amyloid Angiopathy

Snippet

Sponsor: Fondation Hôpital Saint-Joseph | Conditions: Amyloid Angiopathy | Status: COMPLETED